Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Efficacy of thyroid blockade on thyroid radioiodine uptake in 123I-mIBG imaging.

Friedman NC, Hassan A, Grady E, Matsuoka DT, Jacobson AF.

J Nucl Med. 2014 Feb;55(2):211-5. doi: 10.2967/jnumed.113.124826. Epub 2014 Jan 2.

2.

Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.

Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J; ADMIRE-HF Investigators.

J Am Coll Cardiol. 2010 May 18;55(20):2212-21. doi: 10.1016/j.jacc.2010.01.014. Epub 2010 Feb 25.

3.

123I-MIBG myocardial scintigraphy in diabetic patients: relationship with 201Tl uptake and cardiac autonomic function.

Nagamachi S, Jinnouchi S, Kurose T, Ohnishi T, Flores LG 2nd, Nakahara H, Futami S, Tamura S, Matsukura S.

Ann Nucl Med. 1998 Dec;12(6):323-31.

PMID:
9972369
4.

[Quantitative analysis of 123I-metaiodobenzylguanidine myocardial imaging: assessment of its usefulness in patients with congestive heart failure].

Narita M, Kurihara T, Murano K, Usami M, Honda M.

Kaku Igaku. 1994 Apr;31(4):347-58. Japanese.

PMID:
8196231
5.

Quantitation of myocardial iodine-123 MIBG uptake in SPET studies: a new approach using the left ventricular cavity and a blood sample as a reference.

Somsen GA, Borm JJ, de Milliano PA, van Vlies B, Dubois EA, van Royen EA.

Eur J Nucl Med. 1995 Oct;22(10):1149-54.

PMID:
8542899
6.

Clinical evaluation of no-carrier-added meta-[123I]iodobenzylguanidine for myocardial scintigraphy.

Knickmeier M, Matheja P, Wichter T, Schäfers KP, Kies P, Breithardt G, Schober O, Schäfers M.

Eur J Nucl Med. 2000 Mar;27(3):302-7.

PMID:
10774882
7.

Impact of age on myocardial uptake of ¹²³I-mIBG in older adult subjects without coronary heart disease.

Jacobson AF, Chen J, Verdes L, Folks RD, Manatunga DN, Garcia EV.

J Nucl Cardiol. 2013 Jun;20(3):406-14. doi: 10.1007/s12350-013-9701-7. Epub 2013 Mar 13.

PMID:
23483457
8.

Quantitative I-123 mIBG SPECT in differentiating abnormal and normal mIBG myocardial uptake.

Chen J, Folks RD, Verdes L, Manatunga DN, Jacobson AF, Garcia EV.

J Nucl Cardiol. 2012 Feb;19(1):92-9. doi: 10.1007/s12350-011-9438-0. Epub 2011 Dec 7.

PMID:
22147616
10.

Scintigraphic assessment of silent myocardial ischaemia after early infarction using myocardial SPET imaging with 201Tl and 123I-MIBG.

Shimonagata T, Ishida Y, Hayashida K, Takamiya M, Uehara T, Nishimura T.

Nucl Med Commun. 1995 Nov;16(11):893-900.

PMID:
8587753
11.

Kinetics of 123I-MIBG after acute myocardial infarction and reperfusion therapy.

Bengel FM, Barthel P, Matsunari I, Schmidt G, Schwaiger M.

J Nucl Med. 1999 Jun;40(6):904-10.

12.

[Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP].

Yahara Y, Nomura Y, Okamoto S, Saitou K, Okamoto R, Makino K, Aoki S, Takeda K.

Kaku Igaku. 2000 May;37(3):217-25. Japanese.

PMID:
10860352
13.

123I-MIBG myocardial scintigraphy as a noninvasive screen for the diagnosis of coronary artery spasm.

Ha JW, Lee JD, Jang Y, Chung N, Kwan J, Rim SJ, Lee YJ, Shim WH, Cho SY, Kim SS.

J Nucl Cardiol. 1998 Nov-Dec;5(6):591-7.

PMID:
9869481
14.
15.

Cardiac 123I-MIBG uptake is affected by variable uptake in reference regions: implications for interpretation in clinical studies.

Somsen GA, Borm JJ, Dubois EA, Schook MB, Van Der Wall EE, Van Royen EA.

Nucl Med Commun. 1996 Oct;17(10):872-6.

PMID:
8951908
16.

Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid.

Matsui H, Udaka F, Oda M, Tamura A, Kubori T, Nishinaka K, Kameyama M.

Ann Nucl Med. 2005 May;19(3):225-9.

PMID:
15981676
17.

Improved labelling of no-carrier-added 123I-MIBG and preliminary clinical evaluation in patients with ventricular arrhythmias.

Samnick S, Bader JB, Müller M, Chapot C, Richter S, Schaefer A, Sax B, Kirsch CM.

Nucl Med Commun. 1999 Jun;20(6):537-45.

PMID:
10451866
18.

[The heterogeneity of myocardial sympathetic innervation in normal subjects: an assessment by iodine-123 metaiodobenzylguanidine scintigraphy].

D'Alto M, Maurea S, Basso A, Varrella P, Polverino W, Bianchi U, Bonelli A, Salvatore M, Chiariello M.

Cardiologia. 1998 Nov;43(11):1231-6. Italian.

PMID:
9922590
19.

Effect of exercise-induced activation of sympathetic nerve activity on clearance of 123I-MIBG from the myocardium.

Sugihara H, Shiga K, Terada K, Kinoshita N, Taniguchi Y, Ito K, Adachi Y, Ushijima Y, Nakagawa M, Maeda T.

Ann Nucl Med. 1998 Aug;12(4):175-8.

PMID:
9795701
20.

Risk stratification assessed by combined lung and heart iodine-123 metaiodobenzylguanidine uptake in patients with idiopathic dilated cardiomyopathy.

Kamiyoshi Y, Yazaki Y, Urushibata K, Koizumu T, Kasai H, Izawa A, Kinoshita O, Hongo M, Ikeda U.

Am J Cardiol. 2008 May 15;101(10):1482-6. doi: 10.1016/j.amjcard.2008.01.030. Epub 2008 Mar 26.

PMID:
18471462
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk